International Journal of Antimicrobial Agents
Volume 33, Issue 5 , Pages 427-431 , May 2009

A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA)

Received 13 October 2008 ,Accepted 16 October 2008.

References 

  1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532
  2. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–520
  3. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762
  4. Jevons MP. Celbenin-resistant staphylococci. Br Med J. 1961;1:124–125
  5. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother. 2005;56:455–462
  6. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002;30:458–75.
  7. Izumida M, Nagai M, Ohta A, Hashimoto S, Kawado M, Murakami Y, et al. Epidemics of drug-resistant bacterial infections observed in infectious disease surveillance in Japan, 2001–2005. J Epidemiol. 2007;17(Suppl.):S42–S47
  8. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–598
  9. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26:175–183
  10. Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001;7:178–182
  11. Borkow G, Gabbay J. Biocidal textiles can help fight nosocomial infections. Med Hypotheses. 2008;70:990–994
  12. Malnick S, Bardenstein R, Huszar M, Gabbay J, Borkow G. Pyjamas and sheets as a potential source of nosocomial pathogens. J Hosp Infect. 2008;70:89–92
  13. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002;99:7687–7692
  14. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984
  15. Antimicrobial susceptibility testing: BSAC Working Party Report. J Antimicrob Chemother 2001;48(Suppl. S1):5–16.
  16. National Committee for Clinical and Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents: tentative guidelines M26-T. Villanova PA: NCCLS; 1992.
  17. May J, Chan CH, King A, Williams L, French GL. Time–kill studies of tea tree oils on clinical isolates. J Antimicrob Chemother. 2000;45:639–643
  18. European Antimicrobial Resistance Surveillance System. EARSS annual report 2005. Bilthoven, The Netherlands: EARSS; 2006. http://www.rivm.nl/earss/Images/EARSS%202005_tcm61-34899.pdf [accessed 4 November 2008].
  19. French GL, Otter JA, Shannon KP, Adams NM, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004;57:31–37

PII: S0924-8579(08)00527-X

doi: 10.1016/j.ijantimicag.2008.10.020

International Journal of Antimicrobial Agents
Volume 33, Issue 5 , Pages 427-431 , May 2009

Article Tools

* Image Usage & Resolution